Total Payments
$24,285
2024 Payments
$3,367
Companies
11
Transactions
30
Medicare Patients
358
Medicare Billing
$46,337
Payment Breakdown by Category
Consulting$18,240 (75.1%)
Food & Beverage$2,545 (10.5%)
Other$2,000 (8.2%)
Education$1,500 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,240 | 2 | 75.1% |
| Food and Beverage | $2,545 | 26 | 10.5% |
| Honoraria | $2,000 | 1 | 8.2% |
| Education | $1,500 | 1 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $19,229 | 11 | $0 (2024) |
| PFIZER INC. | $2,000 | 1 | $0 (2022) |
| Intuitive Surgical, Inc. | $1,543 | 2 | $0 (2023) |
| Clovis Oncology, Inc. | $761.10 | 8 | $0 (2020) |
| Merck Sharp & Dohme LLC | $159.82 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $136.00 | 1 | $0 (2024) |
| Seagen Inc. | $133.33 | 1 | $0 (2022) |
| TESARO, Inc. | $124.99 | 1 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $102.30 | 1 | $0 (2024) |
| Genmab U.S., Inc. | $69.22 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,367 | 8 | AstraZeneca Pharmaceuticals LP ($2,943) |
| 2023 | $1,612 | 3 | Intuitive Surgical, Inc. ($1,543) |
| 2022 | $2,541 | 6 | PFIZER INC. ($2,000) |
| 2021 | $15,614 | 2 | AstraZeneca Pharmaceuticals LP ($15,614) |
| 2020 | $315.27 | 3 | Clovis Oncology, Inc. ($315.27) |
| 2019 | $835.63 | 8 | Clovis Oncology, Inc. ($445.83) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $124.35 | General |
| 09/25/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), SHINGRIX, ZEJULA | Food and Beverage | In-kind items and services | $136.00 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $129.35 | General |
| 09/04/2024 | Myriad Genetic Laboratories, Inc. | MYCHOICE CDX (Device) | Food and Beverage | In-kind items and services | $102.30 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $35.47 | General |
| 04/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $73.42 | General |
| 01/29/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $69.22 | General |
| Category: Oncology | ||||||
| 02/14/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $42.75 | General |
| Category: SURGERY | ||||||
| 01/31/2023 | Intuitive Surgical, Inc. | DAVINCI XI (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 12/20/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Oncology | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Oncology | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.14 | General |
| 08/11/2022 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $133.33 | General |
| 04/25/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $130.99 | General |
| 03/09/2022 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| 07/15/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $114.04 | General |
| Category: Oncology | ||||||
| 01/06/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $15,500.00 | General |
| Category: Oncology | ||||||
| 10/07/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $107.38 | General |
| Category: Oncology | ||||||
| 01/10/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $88.58 | General |
| Category: Oncology | ||||||
| 01/09/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $119.31 | General |
| Category: Oncology | ||||||
| 12/02/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $117.81 | General |
| Category: Oncology | ||||||
| 10/30/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $131.91 | General |
| 08/12/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $110.07 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 108 | 185 | $38,300 | $13,974 |
| 2022 | 2 | 66 | 121 | $21,546 | $7,862 |
| 2021 | 4 | 87 | 187 | $35,739 | $12,847 |
| 2020 | 4 | 97 | 212 | $36,931 | $11,654 |
Total Patients
358
Total Services
705
Medicare Billing
$46,337
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 90 | $16,988 | $6,202 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $6,936 | $2,465 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 21 | $5,464 | $2,329 | 42.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 36 | $6,480 | $2,211 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 19 | $2,432 | $767.10 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 98 | $18,560 | $6,825 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 23 | $2,986 | $1,038 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 97 | $18,270 | $7,238 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 61 | $10,980 | $3,467 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 13 | $4,420 | $1,398 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 16 | $2,069 | $744.56 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 57 | 137 | $25,550 | $7,959 | 31.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 36 | $6,480 | $2,104 | 32.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 26 | $2,600 | $824.04 | 31.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 13 | 13 | $2,301 | $766.21 | 33.3% |
About Sarah Taylor
Sarah Taylor is a Obstetrics & Gynecology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215194154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Taylor has received a total of $24,285 in payments from pharmaceutical and medical device companies, with $3,367 received in 2024. These payments were reported across 30 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($18,240).
As a Medicare-enrolled provider, Taylor has provided services to 358 Medicare beneficiaries, totaling 705 services with total Medicare billing of $46,337. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Pittsburgh, PA
- Active Since 05/19/2008
- Last Updated 05/24/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1215194154
Products in Payments
- LYNPARZA (Drug) $18,598
- DAVINCI XI (Device) $1,500
- Rubraca (Drug) $761.10
- JEMPERLI (Biological) $136.00
- ZEJULA (Drug) $124.99
- MYCHOICE CDX (Device) $102.30
- Tivdak (Drug) $69.22
- Da Vinci Surgical System (Device) $42.75
- DAXXIFY (Drug) $26.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Pittsburgh
Dr. John Nakayama, M.d, M.D
Obstetrics & Gynecology — Payments: $188,635
Obstetrics & Gynecology $188,635
Dr. Grace Ferguson, Md, MD
Obstetrics & Gynecology — Payments: $18,637
Obstetrics & Gynecology $18,637
Dr. Anita Showalter, Do, DO
Obstetrics & Gynecology — Payments: $15,015
Obstetrics & Gynecology $15,015
Allan Klapper, Md, MD
Obstetrics & Gynecology — Payments: $14,939
Obstetrics & Gynecology $14,939
Dr. Michele Straka, Do, DO
Obstetrics & Gynecology — Payments: $13,692
Obstetrics & Gynecology $13,692
Dr. Eric Lantzman, Md, MD
Obstetrics & Gynecology — Payments: $11,062
Obstetrics & Gynecology $11,062